Irmela Mantel

2.2k total citations
83 papers, 1.4k citations indexed

About

Irmela Mantel is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Irmela Mantel has authored 83 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Ophthalmology, 58 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Molecular Biology. Recurrent topics in Irmela Mantel's work include Retinal Diseases and Treatments (68 papers), Retinal Imaging and Analysis (54 papers) and Retinal and Optic Conditions (42 papers). Irmela Mantel is often cited by papers focused on Retinal Diseases and Treatments (68 papers), Retinal Imaging and Analysis (54 papers) and Retinal and Optic Conditions (42 papers). Irmela Mantel collaborates with scholars based in Switzerland, France and United Kingdom. Irmela Mantel's co-authors include Aude Ambresin, Léonidas Zografos, Ali Dirani, Lazaros Konstantinidis, Francine Béhar‐Cohen, Alexandre Matet, Ann Schalenbourg, Alejandra Daruich, Marta Zola and Jean‐Antoine Pournaras and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Irmela Mantel

80 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Irmela Mantel Switzerland 23 1.3k 984 223 38 37 83 1.4k
Ilaria Zucchiatti Italy 19 973 0.7× 642 0.7× 206 0.9× 18 0.5× 44 1.2× 63 1.1k
Silvana Negrão United States 6 1.2k 0.9× 832 0.8× 162 0.7× 21 0.6× 26 0.7× 8 1.3k
Jennifer Sung United States 15 918 0.7× 656 0.7× 352 1.6× 23 0.6× 49 1.3× 22 1.2k
Allison R. Ayala United States 13 1.5k 1.1× 1.4k 1.4× 223 1.0× 17 0.4× 50 1.4× 24 1.7k
Hanna Rodriguez-Coleman United States 8 1.1k 0.9× 762 0.8× 157 0.7× 21 0.6× 19 0.5× 11 1.2k
Claudia Del Turco Italy 12 669 0.5× 448 0.5× 183 0.8× 26 0.7× 21 0.6× 23 786
Alexandre Sellam France 11 1.1k 0.8× 779 0.8× 137 0.6× 26 0.7× 33 0.9× 25 1.2k
Mauro Goldbaum United States 14 1.3k 1.0× 970 1.0× 317 1.4× 20 0.5× 33 0.9× 25 1.5k
Maria Gemenetzi United Kingdom 12 635 0.5× 352 0.4× 195 0.9× 23 0.6× 32 0.9× 15 717
Yehia Hashad United States 11 1.6k 1.2× 1.1k 1.2× 138 0.6× 15 0.4× 11 0.3× 17 1.7k

Countries citing papers authored by Irmela Mantel

Since Specialization
Citations

This map shows the geographic impact of Irmela Mantel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Irmela Mantel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Irmela Mantel more than expected).

Fields of papers citing papers by Irmela Mantel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Irmela Mantel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Irmela Mantel. The network helps show where Irmela Mantel may publish in the future.

Co-authorship network of co-authors of Irmela Mantel

This figure shows the co-authorship network connecting the top 25 collaborators of Irmela Mantel. A scholar is included among the top collaborators of Irmela Mantel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Irmela Mantel. Irmela Mantel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Somfai, Gábor Márk, Christoph Tappeiner, Katja Hatz, et al.. (2024). Intravitreal Dexamethasone Implant in Anti-Vascular Endothelial Growth Factor Pretreated Diabetic Macular Edema—A Swiss Cohort Study. Pharmaceuticals. 17(9). 1235–1235. 1 indexed citations
2.
Bousquet, Elodie, Camille Chenevier‐Gobeaux, Marta Zola, et al.. (2023). High Levels of C-Reactive Protein with Low Levels of Pentraxin 3 as Biomarkers for Central Serous Chorioretinopathy. SHILAP Revista de lepidopterología. 3(3). 100278–100278. 2 indexed citations
3.
Bousquet, Elodie, et al.. (2022). Clinical Characteristics and Multimodal Imaging Findings of Central Serous Chorioretinopathy in Women versus Men. Journal of Clinical Medicine. 11(6). 1706–1706. 7 indexed citations
4.
Mosinska, Agata, et al.. (2021). Fully-automated atrophy segmentation in dry age-related macular degeneration in optical coherence tomography. Scientific Reports. 11(1). 21893–21893. 20 indexed citations
5.
Romdhane, Khaled Ben, Marta Zola, Alexandre Matet, et al.. (2019). Predictors of treatment response to intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy for choroidal neovascularisation secondary to chronic central serous chorioretinopathy. British Journal of Ophthalmology. 104(7). 910–916. 21 indexed citations
6.
Zola, Marta, Alejandra Daruich, Alexandre Matet, Irmela Mantel, & Francine Béhar‐Cohen. (2018). Two-year follow-up of mineralocorticoid receptor antagonists for chronic central serous chorioretinopathy. British Journal of Ophthalmology. 103(8). 1184–1189. 23 indexed citations
7.
8.
Kowalczuk, Laura, Alexandre Matet, Ali Dirani, et al.. (2016). EFFICACY OF INTRAVITREAL AFLIBERCEPT IN MACULAR TELANGIECTASIA TYPE 1 IS LINKED TO THE OCULAR ANGIOGENIC PROFILE. Retina. 37(12). 2226–2237. 9 indexed citations
9.
Dirani, Ali, et al.. (2015). Risk factors and choroidal changes in patients with unilateral versus bilateral chronic active CSCR. Investigative Ophthalmology & Visual Science. 56(7). 3718–3718. 1 indexed citations
10.
Schalenbourg, Ann & Irmela Mantel. (2015). Œil et cancer.. Revue Médicale Suisse. 11(499).
11.
Schalenbourg, Ann & Irmela Mantel. (2015). Œil et cancer. Revue Médicale Suisse. 11(499). 2395–2398. 1 indexed citations
12.
13.
Mantel, Irmela, Ann Schalenbourg, & Léonidas Zografos. (2013). Evanescent vaso-occlusive choroidal pseudo-tumor with acute painful onset: a presumed vortex vein occlusion. Graefe s Archive for Clinical and Experimental Ophthalmology. 252(5). 753–759. 4 indexed citations
14.
Wolfensberger, Thomas J., Matthias Becker, Gerhard Eich, et al.. (2013). INCIDENCE OF PRESUMED ENDOPHTHALMITIS AFTER INTRAVITREAL INJECTION PERFORMED IN THE OPERATING ROOM. Retina. 34(1). 12–17. 41 indexed citations
15.
Mariani, Alessandro, et al.. (2011). Characteristics of eyes with secondary loss of visual acuity receiving variable dosing ranibizumab for neovascular age-related macular degeneration. Graefe s Archive for Clinical and Experimental Ophthalmology. 249(11). 1635–1642. 36 indexed citations
16.
Konstantinidis, Lazaros, Irmela Mantel, Léonidas Zografos, & Aude Ambresin. (2011). Intravitreal Ranibizumab in the Treatment of Predominantly Hemorrhagic Lesions in Exudative Age-Related Macular Degeneration. Klinische Monatsblätter für Augenheilkunde. 228(4). 288–292. 4 indexed citations
17.
Konstantinidis, Lazaros, Aude Ambresin, Léonidas Zografos, & Irmela Mantel. (2009). Retinal pigment epithelium tears after intravitreal injection of ranibizumab for predominantly classic neovascular membranes secondary to age‐related macular degeneration. Acta Ophthalmologica. 88(7). 736–741. 32 indexed citations
18.
Konstantinidis, Lazaros, et al.. (2009). Intravitreal ranibizumab (Lucentis®) in the treatment of retinal angiomatous proliferation (RAP). Graefe s Archive for Clinical and Experimental Ophthalmology. 247(9). 1165–1171. 44 indexed citations
19.
Mantel, Irmela, et al.. (2008). Genotype-phenotype correlation of age-related macular degeneration: influence of complement factor H polymorphism. British Journal of Ophthalmology. 92(4). 513–517. 24 indexed citations
20.
Abu‐Safieh, Leen, Eranga N. Vithana, Irmela Mantel, et al.. (2006). A large deletion in the adRP gene PRPF31: evidence that haploinsufficiency is the cause of disease.. PubMed. 12. 384–8. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ilaria Zucchiatti Breakdown of academic impact, for papers by Silvana Negrão Breakdown of academic impact, for papers by Jennifer Sung Breakdown of academic impact, for papers by Allison R. Ayala Breakdown of academic impact, for papers by Hanna Rodriguez-Coleman Breakdown of academic impact, for papers by Claudia Del Turco Breakdown of academic impact, for papers by Alexandre Sellam Breakdown of academic impact, for papers by Mauro Goldbaum Breakdown of academic impact, for papers by Maria Gemenetzi Breakdown of academic impact, for papers by Yehia Hashad
Rankless by CCL
2026